scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046058468 |
P356 | DOI | 10.1093/JURBAN/JTH148 |
P932 | PMC publication ID | 3455935 |
P698 | PubMed publication ID | 15466846 |
P5875 | ResearchGate publication ID | 8248515 |
P50 | author | Julio Montaner | Q1712378 |
Robert S Hogg | Q37837778 | ||
Martin T. Schechter | Q40448698 | ||
Evan Wood | Q85344858 | ||
Laura M. Kuyper | Q114738783 | ||
P2860 | cites work | Hospital utilization and costs in a cohort of injection drug users | Q28347872 |
Displacement of Canada's largest public illicit drug market in response to a police crackdown | Q33555028 | ||
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. | Q33576025 | ||
The cost-effectiveness of methadone maintenance as a health care intervention | Q33800680 | ||
Determinants of hospital admission among HIV-positive people in British Columbia | Q34034666 | ||
HIV prevention with drug-using populations--current status and future prospects: introduction and overview. | Q34196368 | ||
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver | Q34431903 | ||
Needle exchange is not enough: lessons from the Vancouver injecting drug use study | Q34432600 | ||
Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside | Q36078678 | ||
The social determinants of emergency department and hospital use by injection drug users in Canada | Q36274713 | ||
Medical complications of intravenous drug use. | Q37924215 | ||
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. | Q39405131 | ||
The effects of intravenous drug use and gender on the cost of hospitalization for patients with AIDS. | Q39415455 | ||
Antiretroviral medication use among injection drug users: two potential futures | Q39541745 | ||
Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa | Q39601844 | ||
Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. | Q39649363 | ||
Injected-drug use: complications and costs in the care of hospitalized HIV-infected patients | Q40740464 | ||
Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990 | Q41928161 | ||
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic | Q42595766 | ||
Variation in health service use among HIV-infected patients | Q43657622 | ||
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L | Q43689007 | ||
Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. | Q44253859 | ||
One world, one hope: the cost of providing antiretroviral therapy to all nations | Q46321952 | ||
Components of difference in HIV seropositivity rate among injection drug users between low- and high-HIV-prevalence regions | Q47577294 | ||
Inpatient health care utilization for patients with HIV and AIDS in the Edinburgh City Hospital. | Q50602207 | ||
Chronic illicit drug use, health services utilization and the cost of medical care. | Q50659727 | ||
HIV transmission and the cost-effectiveness of methadone maintenance. | Q52278638 | ||
Rationale for evaluating North America's first medically supervised safer-injecting facility | Q57671841 | ||
The Impact of a Police Presence on Access to Needle Exchange Programs | Q57671909 | ||
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus | Q68025741 | ||
Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996 | Q73352748 | ||
The costs of triple-drug anti-HIV therapy for adults in the Americas | Q74493790 | ||
HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities | Q74535584 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV transmission | Q49029021 |
P304 | page(s) | 655-660 | |
P577 | publication date | 2004-12-01 | |
P1433 | published in | Journal of Urban Health | Q15760615 |
P1476 | title | The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions | |
P478 | volume | 81 |
Q37143451 | A Needs Assessment of the Number of Comprehensive Addiction Care Physicians Required in a Canadian Setting |
Q33972137 | Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency |
Q34259367 | Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis. |
Q33385078 | Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics |
Q37313080 | Peer support using a mobile access van promotes safety and harm reduction strategies among sex trade workers in Vancouver's Downtown Eastside |
Q36943313 | Physical violence among a prospective cohort of injection drug users: a gender-focused approach |
Q46943291 | Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways |
Q35763461 | Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment |
Q36985312 | The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment. |
Search more.